Menin-MLL inhibitor 19

Overview

Menin-MLL inhibitor 19, a potent exo-aza spiro inhibitor of menin-mll interaction , example A17, extracted from patent WO2019120209A1. Menin-MLL inhibitor 19 can be used for the reseaech of various diseases, such as cancer , myelodysplastic syndrome (MDS) and diabetes.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Epigenetic Reader Domain

Product Information

• Catalog No.: HY-139076
• CAS No.: 2360487-93-8
• Molecular Formula: C30H34F3N7O4S
• Molecular Weight: 645.70
• Purity: 98.32%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 5 mg/mL (7.74 mM); Clear solution
• Availability: In-stock

Source

Original product source